Accupril Recall Issued Over Nitrosamine Contamination
The Accupril recall is the latest in a string of recalls involving hypertension drugs due to nitrosamine contamination, which could increase the risk of cancer with long-term use.
The Accupril recall is the latest in a string of recalls involving hypertension drugs due to nitrosamine contamination, which could increase the risk of cancer with long-term use.
Similar nitrosamine contamination has led to massive Zantac, Chantix, valsartan and metformin recalls in recent years.
A federal judge ruled the plaintiff's complaint contained enough details to support pursuing most of her Belviq colon cancer claims under Ohio law.
The valsartan settlement counsel will attempt to help parties resolve the litigation without the cases having to go to trial.
Data from more than a dozen clinical trials suggest long-term Valsartan use may increase the risk of lung cancer after only two years of use.
The guidance urges manufacturers to maintain good record keeping and product coding which helps facilitate faster recall responses.
Reports suggest more than 100,000 claims have been registered in the Zantac MDL, alleging various cancers were caused by the recalled heartburn pills
Belviq diet pills were recalled in 2020 due to their link to an increased risk of various forms of cancer.
Thousands of lawsuits are being pursued by individuals alleging that recalled Zantac caused cancer. However, MDL expert testimony will only support that the heartburn drug may have caused five specific types of cancer.
Side effects of the diet pill led to a recall in 2020. However, new lawsuits continue to be filed over cancer caused by Belviq.